VMP 42211411000001105

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Hydralazine 25mg tablets
BNF code 0205010J0AAAGAG
Virtual Therapeutic Moiety Hydralazine
Date identifier became valid 1 Sep 2023
Previous product identifier 318649003
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Hydralazine hydrochloride
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 25.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Apresoline 25mg tablets (Advanz Pharma)
Hydralazine 25mg tablets (A A H Pharmaceuticals Ltd)
Hydralazine 25mg tablets (Accord-UK Ltd)
Hydralazine 25mg tablets (Alliance Healthcare (Distribution) Ltd)
Hydralazine 25mg tablets (Almus Pharmaceuticals Ltd)
Hydralazine 25mg tablets (Medihealth (Northern) Ltd)
Hydralazine 25mg tablets (Morningside Healthcare Ltd)
Hydralazine 25mg tablets (Phoenix Healthcare Distribution Ltd)
Hydralazine 25mg tablets (Sigma Pharmaceuticals Plc)
Hydralazine 25mg tablets (Sigma Pharmaceuticals Plc)
Hydralazine 25mg tablets (Viatris UK Healthcare Ltd)
Virtual Medicinal Product Packs
Hydralazine 25mg tablets 100 tablet
Hydralazine 25mg tablets 500 tablet
Hydralazine 25mg tablets 56 tablet
Hydralazine 25mg tablets 84 tablet

dm+d data retrieved from TRUD: release NHSBSA_12.2.0_20241216000001, imported on 17th December 2024 at 04:01:15.

Feedback